Taken from the 4C-
"The Company also progressed the launch of a private label called “Perform collagen membrane” (Striate+ product branded as Perform) with a subsidiary of Henry Schein. The Henry Schein subsidiary plans to launch Perform at the American Association of Oral and Maxillofacial Surgeons (AAOMS) meeting in San Diego, Calif (September 18, 2023). The subsidiary will market and distribute Perform on the same terms and conditions in the BioHorizons global licence and distribution agreement. Adding the subsidiary to the list of US distributors, will increase the representation of the product and assist in servicing a wide range of dental customers in the US."
Judging by the Patent number and Attorney Mary A. Donovan this shows the Subsidiary in Brockton, Massachusetts as the ACE Surgical Supply Co. a Worldwide distributor of dental and medical healthcare products, services and supplies.
"ACE Focus is being the leading dental surgical supplier by bringing innovative products and solutions to our customers around the world. With over 90 years of combined expertise and a comprehensive product portfolio, ACE SOUTHERN is a strong resource for today’s busy dental practice. We pride ourselves on delivering a great customer experience each time, whether it’s in person, over the phone, or through our website, we always strive to exceed your expectations."
![]()
Column 1 Column 2 Column 3 0 1 Subsidiaries Jurisdiction of incorporation or organization 2 ACE Surgical Supply Co.1 Massachusetts 3 BioHorizons, Inc.2 Delaware 4 Camlog USA, Inc.3 Delaware 5 Exan Enterprises Inc.4 Nevada 6 General Injectables & Vaccines, Inc.5 Virginia 7 Handpiece Parts & Repairs, Inc. Delaware 8 Henry Schein Europe, Inc.6 Delaware 9 Henry Schein Latin America Pacific Rim, Inc.7 Delaware 10 Henry Schein Medical Systems, Inc. Ohio 11 Henry Schein Practice Solutions Inc.8 Utah 12 HS Brand Management Inc. Delaware 13 HS TM Holdings, LLC9 Delaware 14 Project Helium Holdings, LLC10 Delaware 15 Project Spartan Holdings Corp.11 Delaware 16 SG Healthcare Corp.12 Delaware
Equates to more distribution of Striate+ and greater revenue in the long term.
- Forums
- ASX - By Stock
- OCC
- Ann: Quarterly Activity Report & Appendix 4C
Ann: Quarterly Activity Report & Appendix 4C, page-22
-
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
36.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.40M |
Open | High | Low | Value | Volume |
36.5¢ | 36.5¢ | 36.5¢ | $7.753K | 21.24K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 53033 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 48304 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 53033 | 0.360 |
4 | 115227 | 0.355 |
11 | 238030 | 0.350 |
3 | 88988 | 0.345 |
2 | 45000 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 48304 | 2 |
0.375 | 32756 | 2 |
0.380 | 37845 | 4 |
0.385 | 40000 | 1 |
0.390 | 21502 | 4 |
Last trade - 15.24pm 03/07/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online